From October 1, 2021 to December 31, 2021, the company has repurchased 3,390,700 shares, representing 0.31% for CNY 93.27 million. With this, the company has completed the repurchase of 12,070,607 shares, representing 1.09% for CNY 327.78 million under the buyback announced on July 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.1 CNY | +0.72% |
|
+5.01% | -13.96% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.96% | 4.2B | |
+26.19% | 45.32B | |
+34.64% | 24.51B | |
+26.79% | 16.85B | |
+22.10% | 14.62B | |
+73.10% | 14.16B | |
-0.05% | 6.79B | |
-11.25% | 6.73B | |
+18.15% | 5.82B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on July 26, 2021.